Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 27(4): 327-39, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18684804

RESUMO

Siderosis bulbi is vision threatening. An investigation into its mechanisms and management is crucial. Experimental siderosis was established by intravitreous administration of an iron particle (chronic) or FeSO(4) (acute). After siderosis, there was a significant dose-responsive reduction in eletroretinogram (a/b-wave) amplitude, and an increase in OH level, greater when caused by 24 mM FeSO(4) than that by 8 mM FeSO(4). Furthermore, the FeSO(4)-induced oxidative stress was significantly blunted by 100 microM ferulic acid (FA). Siderosis also resulted in an excessive glutamate release, increased [Ca(++)](i), and enhanced superoxide dismutase immunoreactivity. The latter finding was consistent with the Western blot result. Obvious disorganization including loss of photoreceptor outer segments and cholinergic amacrines together with a wide-spreading ferric distribution across the retina was present, which were related to the eletro-retinographic and pathologic dysfunctions. Furthermore, b-wave reduction and amacrine damage were respectively, significantly, dose-dependently, and clearly ameliorated by FA. Thus, siderosis stimulates oxidative stress, and possibly, subsequent excitotoxicity, and calcium influx, which explains why the retina is impaired electro-physiologically and pathologically. Importantly, FA protects iron toxicity perhaps by acting as a free radical scavenger. This provides an approach to the study and treatment of the iron-related disorders such as retained intraocular iron and Alzheimer disease.


Assuntos
Ácidos Cumáricos/uso terapêutico , Compostos Ferrosos/toxicidade , Ferro/toxicidade , Retina/efeitos dos fármacos , Doenças Retinianas/prevenção & controle , Siderose/tratamento farmacológico , Doença Aguda , Animais , Cálcio/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Doença Crônica , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Antagonismo de Drogas , Eletrorretinografia/efeitos dos fármacos , Compostos Ferrosos/análise , Compostos Ferrosos/metabolismo , Glutamatos/metabolismo , Radical Hidroxila/metabolismo , Radical Hidroxila/toxicidade , Injeções , Ferro/análise , Ferro/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Retina/metabolismo , Retina/fisiopatologia , Doenças Retinianas/induzido quimicamente , Doenças Retinianas/fisiopatologia , Siderose/etiologia , Siderose/patologia , Superóxido Dismutase/metabolismo , Corpo Vítreo/química , Corpo Vítreo/efeitos dos fármacos , Corpo Vítreo/metabolismo
2.
Brain Res ; 904(1): 126-36, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11516418

RESUMO

Ischaemia was induced to the rat retina by raising the intraocular pressure above the systolic blood pressure for 45 min. After a reperfusion period of 5 days, alterations in the localisation of choline acetyltransferase (ChAT) and calretinin immunoreactivities, a reduction in the thickness of the inner retinal layers and a decline in the b-wave amplitude of the electroretinogram were recorded. These changes were blunted when clonidine was injected intraperitoneally before or after ischaemia or when applied topically by a specific regime. Other alpha(2)-adrenoceptor agonists, brimonidine and apraclonidine, acted in a similar way to clonidine when applied topically but because of the number of experiments carried out a comparison between the effectiveness of the different alpha(2)-adrenoceptor agonists was not possible. The protective effect of clonidine was attenuated when the alpha(2)-adrenoceptor antagonists yohimbine or rauwolscine were co-administered, suggesting that the mechanism of action of the drug is to stimulate alpha(2)-adrenoceptors. In addition, the imidazoline receptor ligands, BU-226 and AGN-192403 did not blunt the effect of ischaemia/reperfusion, supporting the notion that the protective action of the alpha(2)-adrenoceptor agonists does not involve imidazoline sites but rather the activation of alpha(2)-adrenoceptors. The protective effect of 0.5% clonidine appeared to be greater when topically applied to the eye that received ischaemia than when applied by the same regime to the contralateral eye. These studies suggest that while most of topically applied clonidine reaches the retina by a systemic route one cannot rule out additional pathways.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Clonidina/farmacologia , Fármacos Neuroprotetores/farmacologia , Receptores Adrenérgicos alfa 2/efeitos dos fármacos , Receptores de Droga/efeitos dos fármacos , Traumatismo por Reperfusão/tratamento farmacológico , Retina/efeitos dos fármacos , Antagonistas Adrenérgicos alfa/farmacologia , Animais , Compostos Bicíclicos com Pontes/farmacologia , Tartarato de Brimonidina , Calbindina 2 , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Colina O-Acetiltransferase/efeitos dos fármacos , Colina O-Acetiltransferase/metabolismo , Clonidina/análogos & derivados , Eletrorretinografia/efeitos dos fármacos , Heptanos/farmacologia , Receptores de Imidazolinas , Imuno-Histoquímica , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Degeneração Neural/tratamento farmacológico , Degeneração Neural/metabolismo , Degeneração Neural/fisiopatologia , Quinoxalinas/farmacologia , Ratos , Ratos Wistar , Receptores Adrenérgicos alfa 2/metabolismo , Receptores de Droga/agonistas , Traumatismo por Reperfusão/metabolismo , Traumatismo por Reperfusão/fisiopatologia , Retina/metabolismo , Retina/fisiopatologia , Células Ganglionares da Retina/efeitos dos fármacos , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/patologia , Proteína G de Ligação ao Cálcio S100/efeitos dos fármacos , Proteína G de Ligação ao Cálcio S100/metabolismo , Ioimbina/farmacologia
3.
Exp Eye Res ; 72(1): 79-86, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11133185

RESUMO

It has previously been reported that the beta(1)-adrenoceptor antagonist, betaxolol, can protect retinal neurones from ischaemia when applied topically. It has further been shown that betaxolol can reduce influx of both sodium or calcium into neurones through interaction at neurotoxin site 2 of the sodium channel and the L-type calcium channel, respectively. The present study sought to further investigate the neuroprotective mode of action of betaxolol in the rat retina. Rats were treated topically with L-betaxolol for 10, 5 and 1 min before ischaemia, induced by raising the intraocular pressure above systolic blood pressure for 45 min. This was followed by reperfusion of 3 or 5 days where L-betaxolol was applied topically twice daily. Ischaemia plus reperfusion caused both a loss of immunoreactivity for choline acetyl transferase (ChAT) and a marked reduction of the b-wave of the electroretinogram (ERG). Treatment, as described, with topical L-betaxolol, completely blunted the effects upon ChAT immunoreactivity and caused a significant reversal of the ERG changes. Furthermore, other rats treated topically with commercially available racemic betaxolol (Betoptic Solution, 0.5%) for 6 hr had raised levels of mRNA for brain derived neurotrophic factor (BDNF) but not for basic fibroblast growth factor (bFGF) in their retinas. The combined data provide further evidence that betaxolol can blunt the effects of ischaemia to the rat retina when applied topically just before the insult. Furthermore, the finding that retinal levels of BDNF mRNA are raised following topical betaxolol treatment shows that not only can this drug reach the retina but that it can also induce changes in expression of factors which are known, themselves, to provide neuroprotection to retinal neurones.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Betaxolol/uso terapêutico , Isquemia/tratamento farmacológico , Fatores de Crescimento Neural/efeitos dos fármacos , Retina/efeitos dos fármacos , Animais , Colina O-Acetiltransferase/efeitos dos fármacos , Colina O-Acetiltransferase/metabolismo , Eletrorretinografia , Fatores de Crescimento Neural/genética , Soluções Oftálmicas , RNA Mensageiro/efeitos dos fármacos , Ratos , Ratos Wistar , Vasos Retinianos/efeitos dos fármacos
4.
Eye (Lond) ; 14 ( Pt 3B): 454-63, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11026974

RESUMO

Various classes of compounds exist to lower intraocular pressure (IOP) in the treatment of glaucoma. None of them is ideal since some patients respond better than others and the side effects vary between individuals. New classes of compounds need to be introduced to allow the clinician greater scope for effective treatment of all patients. It is now generally agreed that the cause of ganglion cell dysfunction in glaucoma is likely to be multifactorial and that concentrating solely on reducing IOP is inadequate. Irrespective of the reason for the dysfunction, the future goal must be to attenuate cell death. This may be achieved with drugs that interact with components of the retina, and is termed 'neuroprotection'. Thus, drugs that can both reduce IOP and act as neuroprotectants would be ideal for the treatment of glaucoma. In this article we summarise studies on animals which show serotonergic 5-HT1A agonists to both reduce IOP when topically applied to the rabbit eye and blunt the damaging effect to the rat retina and ganglion cells induced by glutamate toxicity or ischaemia. Reduction of IOP occurs via stimulation of 5-HT1A receptors associated with the ciliary processes. Neuroprotection of retinal neurones appears to involve the interaction of 5-HT1A agonists with membrane sodium channels and/or 5-HT1A or even possibly 5-HT7 receptors. Various 5-HT1A agonists are used in patients to treat depression, so classes of these drugs have a proven safety profile for use in patients. The animal studies summarised in this article suggest that 5-HT1A agonists need to be considered as a new class of drugs for the treatment of glaucoma.


Assuntos
Glaucoma/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Agonistas do Receptor de Serotonina/uso terapêutico , 8-Hidroxi-2-(di-n-propilamino)tetralina/agonistas , 8-Hidroxi-2-(di-n-propilamino)tetralina/uso terapêutico , Animais , Pressão Intraocular/efeitos dos fármacos , Coelhos , Ratos , Receptores de Serotonina/metabolismo , Retina/metabolismo
5.
Brain Res ; 877(1): 47-57, 2000 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10980242

RESUMO

alpha(2)-adrenoceptor agonists, such as clonidine, attenuate hypoxia-induced damage to brain and retinal neurones by a mechanism of action which likely involves stimulation of alpha(2)-adrenoceptors. In addition, the neuroprotective effect of alpha(2)-adrenoceptor agonists in the retina may involve stimulation of bFGF production. The purpose of this study was to examine more thoroughly the neuroprotective properties of clonidine. In particular, studies were designed to ascertain whether clonidine acts as a free radical scavenger. It is thought that betaxolol, a beta(1)-adrenoceptor antagonist, acts as a neuroprotective agent by interacting with sodium and L-type calcium channels to reduce the influx of these ions into stressed neurones. Studies were therefore undertaken to determine whether clonidine has similar properties. In addition, studies were undertaken to determine whether i.p. injections of clonidine or betaxolol affect retinal bFGF mRNA levels. In vitro data were generally in agreement that clonidine and bFGF counteracted the effect of NMDA as would occur in hypoxia. No evidence could be found that clonidine interacts with sodium or L-type calcium channels, reduces calcium influx into neurones or acts as a free radical scavenger at concentrations below 100 microM. Moreover, i.p. injection of clonidine, but not betaxolol, elevated bFGF mRNA levels in the retina. The conclusion from this study is that the neuroprotective properties of alpha(2)-adrenoceptor agonists, like clonidine, are very different from betaxolol. The fact that both betaxolol and clonidine blunt hypoxia-induced death to retinal ganglion cells suggests that combining the two drugs may be a way forward to producing more effective neuroprotection.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Clonidina/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Retina/efeitos dos fármacos , Antagonistas Adrenérgicos beta/farmacologia , Animais , Batraquiotoxinas/metabolismo , Betaxolol/farmacologia , Bloqueadores dos Canais de Cálcio/metabolismo , Córtex Cerebral/metabolismo , Embrião de Galinha , Fator 2 de Crescimento de Fibroblastos/fisiologia , Fármacos Neuroprotetores/farmacologia , Neurotoxinas/metabolismo , Nitrendipino/metabolismo , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Coelhos , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/fisiologia , Retina/metabolismo , Saxitoxina/metabolismo , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/metabolismo
6.
Endocrinology ; 139(7): 3112-8, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9645683

RESUMO

Adrenal steroids and neurotrophic factors are important modulators of neuronal plasticity, function, and survival in the rat hippocampus. Adrenal steroids act through two receptor subtypes, the glucocorticoid receptor (GR) and the mineralocorticoid receptor, and activation of each receptor subtype has distinct biochemical and physiological consequences. Adrenal steroids may exert their effects on neuronal structure and function through the regulation of expression of neurotrophic and growth-associated factors. We have examined adrenal steroid regulation of the neurotrophins brain-derived neurotrophic factor, neurotrophin-3, and basic fibroblast growth factor, as well as the growth associated protein GAP-43, through activation of GR or mineralocorticoid receptor with selective agonists. Our findings indicated that in CA2 pyramidal cells, adrenalectomy resulted in decreases in the levels of basic fibroblast growth factor and neurotrophin-3 messenger RNA, which were prevented by activation of mineralocorticoid but not glucocorticoid receptors. Adrenalectomy-induced increases in GAP-43 and brain-derived neurotrophic factor messenger RNA levels could be blocked by activation of glucocorticoid receptors in CA1, but not in CA3, pyramidal cells. Thus the extent to which adrenal steroids regulate hippocampal neurotrophic and growth-associated factors, appears to be dependent both on the adrenal steroid receptor subtype activated and on the hippocampal subregion examined.


Assuntos
Aldosterona/farmacologia , Corticosterona/farmacologia , Hipocampo/metabolismo , Fatores de Crescimento Neural/metabolismo , Adrenalectomia , Androstanóis/farmacologia , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Fator 2 de Crescimento de Fibroblastos/metabolismo , Proteína GAP-43/metabolismo , Masculino , Neurotrofina 3 , Ratos , Ratos Sprague-Dawley
7.
Endocrinology ; 139(4): 1810-4, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9528966

RESUMO

Adrenal steroids can have prodigious effects on the structure, function, and survival of hippocampal neurons. In the rat hippocampus, the actions of adrenal steroids are mediated by two receptor types, the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). Using in situ hybridization, we have examined the regulation of the messenger RNAs (mRNAs) encoding the glucocorticoid and mineralocorticoid receptors, by aldosterone, which acts selectively through MR, and by RU28362, which acts selectively through GR. Our results demonstrate that there is autoregulation of each receptor subtype, such that activation of GR regulates GR mRNA levels and MR activation regulates MR mRNA expression. In addition, there is evidence that aldosterone, acting through MR, can affect the expression of GR mRNA. The extent to which a specific agonist can produce a significant change in the expression of a particular steroid receptor mRNA varies between the different subfields of the hippocampus.


Assuntos
Aldosterona/farmacologia , Androstanóis/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/metabolismo , RNA Mensageiro/metabolismo , Receptores de Glucocorticoides/genética , Receptores de Mineralocorticoides/genética , Adrenalectomia , Animais , Corticosterona/farmacologia , Hibridização In Situ , Masculino , Ratos , Ratos Sprague-Dawley
8.
Brain Res Mol Brain Res ; 47(1-2): 177-82, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9221915

RESUMO

Ginsenoside Rb1 (Rb1), a saponin of North American ginseng (Panax quinquefolium L.), has been found to exert beneficial effects on memory and learning, putatively through its actions on the cholinergic system. In situ hybridization studies show that Rb1 increases the expression of choline acetyltransferase and trkA mRNAs in the basal forebrain and nerve growth factor mRNA in the hippocampus. Other neurotrophins (brain-derived neurotrophic factor, neurotrophin-3), genes encoding neuropeptides (preproenkephalin, preprotachykinin) and amyloid protein precursor were also studied, but no significant change was observed. These findings support the specificity of the effects of Rb1 on certain aspects of the cholinergic and neurotrophic systems.


Assuntos
Encéfalo/efeitos dos fármacos , Fármacos do Sistema Nervoso Central/farmacologia , Colina O-Acetiltransferase/efeitos dos fármacos , Fatores de Crescimento Neural/metabolismo , Proteínas Tirosina Quinases/efeitos dos fármacos , Saponinas/farmacologia , Animais , Encéfalo/metabolismo , Ginsenosídeos , Hibridização In Situ , Masculino , Fatores de Crescimento Neural/efeitos dos fármacos , Proteínas Tirosina Quinases/metabolismo , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley
11.
Brain Res Mol Brain Res ; 26(1-2): 271-6, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7854057

RESUMO

The genes encoding brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and basic fibroblast growth factor (bFGF) are all expressed in the adult rat hippocampus. The colocalization of the these factors with the receptors to which they bind, namely trkB, trkC and the bFGF receptor, respectively, suggests that in the hippocampus they may exert their putative protective and trophic effects through an autocrine mechanism. The morphology and survival of hippocampal neurons are also affected by glucocorticoids, which can act as transcriptional activators of gene expression. In this study we have used in situ hybridization to investigate the adrenal steroid regulation of the mRNAs encoding the neurotrophic factors BDNF, NT-3, and bFGF, their respective receptors, and the growth-associated protein GAP-43. After 7 days of adrenalectomy (ADX), there was an increase in the level of GAP-43 mRNA expression in the CA1 and CA3 pyramidal cell layers of the hippocampus, that was prevented by corticosterone replacement to the ADX animals. In the CA2 subregion, adrenalectomy resulted in a decrease in bFGF mRNA expression, that was reversed by steroid treatment. There was evidence for glucocorticoid modulation of the BDNF and NT-3 mRNAs in pyramidal cell layers and in the dentate gyrus, but not of the mRNAs encoding the trkB, trk C or bFGF receptors.


Assuntos
Corticosterona/farmacologia , Fator 2 de Crescimento de Fibroblastos/biossíntese , Expressão Gênica/efeitos dos fármacos , Hipocampo/metabolismo , Fatores de Crescimento Neural/biossíntese , Células Piramidais/metabolismo , Receptores de Fator de Crescimento Neural/biossíntese , Adrenalectomia , Animais , Elementos Antissenso (Genética) , Fator Neurotrófico Derivado do Encéfalo , Relação Dose-Resposta a Droga , Hipocampo/efeitos dos fármacos , Masculino , Proteínas do Tecido Nervoso/biossíntese , Neurotrofina 3 , Sondas de Oligonucleotídeos , Células Piramidais/efeitos dos fármacos , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Receptores Proteína Tirosina Quinases/biossíntese , Receptor do Fator Neutrófico Ciliar , Receptor trkC
12.
J Neuroendocrinol ; 6(5): 517-21, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7827621

RESUMO

In the rat hippocampus, neuronal morphology and survival are profoundly affected by adrenal steroids, and synaptic plasticity can be modulated by the ovarian sex steroids estrogen and progesterone. beta-amyloid peptides, which accumulate in neuritic plaques and are derived from the amyloid precursor protein (APP), have been shown to be both trophic and toxic for hippocampal neurons. Of the various APP isoforms, APP695 is the predominant form found in rat brain and the APP695 mRNA is abundantly expressed in the hippocampus. In order to investigate the hypothesis that APP may serve as a mediator of the steroid effects, we have monitored the hippocampal expression of APP695 mRNA by in situ hybridization, with aging and with steroid manipulation. In aged female rats we observed a decrease in the level of APP695 mRNA relative to young female rats, while no such age difference was evident in male rats. Physiological, surgical and pharmacological manipulation of glucocorticoids appeared to have no effect on APP695 mRNA levels in the hippocampus. Treatment of young, ovariectomized female rats with estrogen and progesterone, resulted in an increase in hippocampal APP695 expression compared to untreated, ovariectomized controls.


Assuntos
Envelhecimento/metabolismo , Precursor de Proteína beta-Amiloide/genética , Estrogênios/fisiologia , Expressão Gênica , Glucocorticoides/fisiologia , Hipocampo/metabolismo , Progesterona/fisiologia , Adrenalectomia , Animais , Sequência de Bases , Estradiol/farmacologia , Estrogênios/farmacologia , Feminino , Glucocorticoides/farmacologia , Masculino , Dados de Sequência Molecular , Ovariectomia , Progesterona/farmacologia , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley
15.
Mol Cell Neurosci ; 4(2): 181-90, 1993 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19912921

RESUMO

The present studies were undertaken to determine whether hippocampal glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) biosynthesis, as inferred from mRNA expression, exhibit diurnal patterns of activation which may reflect or predict changes in plasma adrenocorticosteroid levels. Animals received either adrenalectomy (ADX) or sham adrenalectomy and were sacrificed at 4-h intervals throughout the diurnal cycle. Hippocampal and control brain areas were assayed for regional GR and MR mRNA changes via semiquantitative in situ hybridization histochemical analysis. The results indicate subfield-specific significant circadian rhythms in both GR and MR mRNAs. A significant diurnal rhythm in GR mRNA expression was seen in the dentate gyrus (DG), which took the shape of a monotonic curve with a marked trough at 1500 h after lights on (1 h after lights off). A similar pattern was evident in subfield CA1, although the effect fell short of statistical significance. No rhythm was seen in CA3. In response to ADX, GR mRNA was markedly increased in both CA1 and CA3; these increases appeared to be independent of circadian influences. In contrast, ADX effects in DG were quite limited and appeared to eliminate the circadian GR mRNA trough. Bimodal diurnal rhythms in MR mRNA expression were observed in all subfields and commonly exhibited troughs at 1500 h after lights on and 0300 h after lights on. These rhythms appeared to be related to circulating steroids, as ADX eliminated both the 1500 and 0300 h troughs, resulting in flat levels of MR mRNA expression corresponding roughly to the circadian peak. Notably, no diurnal GR or MR mRNA rhythms were observed in frontoparietal cortex, nor were any GR mRNA changes seen in the dorsomedial thalamus or hypothalamic paraventricular nucleus. Indeed, ADX was ineffective in altering adrenocorticosteroid receptor mRNA expression in any extrahippocampal region examined. These results indicate that GR and MR mRNAs exhibit hippocampus-specific diurnal rhythms in expression which are controlled to a greater (MR) or lesser (GR) extent by circulating steroids. The apparent steroid sensitivity of hippocampal adrenocorticosteroid receptor populations may be involved in the expression of rhythmic changes in hippocampal function associated with HPA regulation and information processing.

16.
Mol Cell Neurosci ; 4(6): 543-8, 1993 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19912962

RESUMO

The housing of male and female rats in a visible burrow system in which a dominance hierarchy is established and interactions between animals can be monitored provides an effective method by which the behavioral and neuroendocrine effects of social stress can be examined. In this social system, subordinate male rats exhibit plasma corticosterone levels that appear to be chronically elevated relative to the dominant rats in the colonies and compared to singly housed controls. Previous studies have indicated that in the hippocampus adrenal steroids negatively regulate the expression of the mRNAs encoding the glucocorticoid receptor (GR), the mineralocorticoid receptor (MR), and the growth-associated protein GAP-43, while the preproenkephalin (ppENK) mRNA is positively regulated by glucocorticoids. This study examined the effect of social stress and the resulting sustained increase in steroid levels in the subordinate animals on gene expression in the hippocampus. The results indicated that GR, MR, and GAP-43 mRNAs were decreased in subordinate rats relative to controls, in the CA1 region of the hippocampus, while ppENK mRNA was unaffected. No statistically significant differences in mRNA expression were observed in other hippocampal subfields. These findings suggest that the social stress encountered by the subordinate rats in this burrow environment elicits changes in hippocampal gene expression that are consistent with their regulation by adrenal steroids.

18.
Mol Cell Neurosci ; 3(6): 529-35, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19912896

RESUMO

GAP-43 is expressed in axonal growth cones during development and regeneration. High levels of GAP-43 persist in the adult hippocampus, reflecting perhaps the ongoing neurogenesis and synaptic plasticity characteristic of this brain region. Since the morphology and survival of hippocampal neurons are altered by adrenal steroids and aging, we have investigated the effects of adrenalectomy and of aging on the expression of hippocampal GAP-43 mRNA, as a molecular marker for these events. Adrenalectomy for 7 days results in an increase in GAP-43 mRNA expression, as assessed by in situ hybridization, in the pyramidal cell layers of the hippocampus. Both male and female aged rats exhibit levels of GAP-43 mRNA in hippocampal pyramidal cells lower than those of their younger counterparts.

19.
Brain Res Mol Brain Res ; 9(4): 307-11, 1991 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1645434

RESUMO

Expression of the preprotachykinin (PPT) mRNA and of the preproenkephalin (PPE) mRNA in the rat striatum has been assessed by in situ hybridization. The results demonstrate that the PPT mRNA is regulated by glucocorticoids such that adrenalectomized (ADX) animals replaced with corticosterone for 5 days expressed higher levels of the mRNA than ADX animals. The corticosterone-induced increase in striatal PPT mRNA was evident after 16 h, but not after 2 h, of corticosterone treatment of ADX animals. Elevation of circulating corticosterone levels in intact rats by acute restraint stress, or by corticosterone injection did not change the level of PPT mRNA in the striatum. In intact rats there was a diurnal variation in the level of striatal PPE mRNA expression; adrenalectomy resulted in a decrease in the mRNA level and did not abolish the diurnal variation in expression. The level of PPT mRNA in the striatum was also decreased in response to ADX, but there were no significant diurnal changes in the expression of the PPT mRNA either in the intact or in the ADX animals.


Assuntos
Corpo Estriado/fisiologia , Corticosterona/farmacologia , Encefalinas/genética , Neuropeptídeos/genética , Precursores de Proteínas/genética , RNA Mensageiro/genética , Taquicininas/genética , Adrenalectomia , Animais , Ritmo Circadiano , Corpo Estriado/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Masculino , Hibridização de Ácido Nucleico , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos
20.
Endocrinology ; 126(6): 3124-30, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2351111

RESUMO

Glucocorticoids regulate the level of preproenkephalin mRNA expression in a number of cell systems. This study investigated the expression of preproenkephalin mRNA in the brain and its regulation by glucocorticoids in vivo. Two different methods for mRNA quantitation were employed. Total RNA isolated from dissected brain tissue was analyzed in an RNAse T2 protection assay. In addition, we have used in situ hybridization to brain sections to assess the expression of preproenkephalin mRNA. The results demonstrate that in the striatum the preproenkephalin mRNA is expressed at a high level and is regulated by glucocorticoids. There is a decrease in striatal preproenkephalin mRNA after adrenalectomy (ADX), and ADX animals replaced with corticosterone express higher levels of striatal preproenkephalin mRNA than ADX animals. By in situ hybridization we have determined that the corticosterone-induced increase in striatal preproenkephalin mRNA is evident after 16 h, but not after 2 h, of corticosterone replacement of ADX animals. Elevation of circulating corticosterone levels in intact rats by 2-3 h of restraint stress, a multiple daily stress regimen over 1-21 days, or corticosterone injection did not change the level of preproenkephalin mRNA in the striatum; however, a single 16-h restraint stress resulted in a decreased level of expression. In intact rats there was a diurnal variation in the level of striatal preproenkephalin mRNA expression; ADX resulted in a decrease in the mRNA level, but did not abolish the diurnal variation in expression. Thus, while there is clearly regulation of striatal preproenkephalin mRNA by glucocorticoids, our results provide evidence for regulation by nonglucocorticoid mechanisms as well.


Assuntos
Corpo Estriado/metabolismo , Encefalinas/genética , Regulação da Expressão Gênica , Glucocorticoides/fisiologia , Precursores de Proteínas/genética , RNA Mensageiro/biossíntese , Adrenalectomia , Animais , Encéfalo/metabolismo , Ritmo Circadiano , Corticosterona/sangue , Corticosterona/farmacologia , Masculino , Hibridização de Ácido Nucleico , Ratos , Ratos Endogâmicos , Restrição Física , Estresse Fisiológico/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...